LifeSci noted the combined company is expected to have approximately $60 million in cash at closing if shareholders approve the deal. Vincera shareholders will own approximately 40% of the issued and outstanding common stock of the combined company, excluding warrants. Read more.
Related Posts
dMY III Sets Vote Date on $2B IonQ Deal
The deal calls for $650 million in gross proceeds to IonQ.
C5 Acquisition to Liquidate, Discloses Sponsor Did Not Make Required $235K Extension Payment Last Month
C5 disclosed that its sponsor did not make the deposit for a one-month extension -- and the sponsor evidently does not intend to do so, as the SPAC noted "there can be no assurance that such amount will be collected." How this news will sit with investors is still unknown.
Healthcare SPAC NorthView Acquisition Files for $180M IPO
The SPAC expects to target small-cap healthcare companies that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space.
Edify Acquisition Converts 6.9M Class B Shares to Class A
The SPAC has a merger agreement with Unique Logistics, a global logistics and freight forwarding company. The deal was announced in December 2022.